PPRC1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.877400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.066000E-01
Normal-vs-Stage2
5.528600E-01
Normal-vs-Stage3
7.521600E-01
Normal-vs-Stage4
2.278400E-02
Stage1-vs-Stage2
7.214400E-01
Stage1-vs-Stage3
4.776800E-01
Stage1-vs-Stage4
2.903600E-02
Stage2-vs-Stage3
2.750600E-01
Stage2-vs-Stage4
3.744200E-02
Stage3-vs-Stage4
2.839900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.106000E-01
Normal-vs-AfricanAmerican
3.673200E-01
Normal-vs-Asian
4.136000E-01
Caucasian-vs-AfricanAmerican
9.490000E-01
Caucasian-vs-Asian
8.574800E-01
AfricanAmerican-vs-Asian
9.249800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.449200E-01
Normal-vs-Female
6.162600E-01
Male-vs-Female
7.261800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.753000E-01
Normal-vs-Age(41-60Yrs)
3.643800E-01
Normal-vs-Age(61-80Yrs)
6.604000E-01
Normal-vs-Age(81-100Yrs)
8.022200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.770200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.556600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.260200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.681400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.867600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.516400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.793000E-01
Normal-vs-Daily Drinker
7.457000E-01
Normal-vs-Weekly Drinker
1.985620E-01
Normal-vs-Occasional Drinker
3.309800E-01
Normal-vs-Social Drinker
5.638200E-01
Non Drinker-vs-Daily Drinker
7.127400E-01
Non Drinker-vs-Weekly Drinker
2.912500E-02
Non Drinker-vs-Occasional Drinker
2.601200E-01
Non Drinker-vs-Social Drinker
4.718400E-01
Daily Drinker-vs-Weekly Drinker
7.290200E-02
Daily Drinker-vs-Occasional Drinker
4.728800E-01
Daily Drinker-vs-Social Drinker
7.150600E-01
Weekly Drinker-vs-Occasional Drinker
1.452820E-01
Weekly Drinker-vs-Social Drinker
1.502350E-01
Occasional Drinker-vs-Social Drinker
7.618800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.121800E-01
Normal-vs-Grade 2
4.559800E-02
Normal-vs-Grade 3
1.354980E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.187600E-02
Grade 1-vs-Grade 3
1.319670E-02
Grade 1-vs-Grade 4
3.121800E-01
Grade 2-vs-Grade 3
1.526190E-01
Grade 2-vs-Grade 4
4.559800E-02
Grade 3-vs-Grade 4
1.354980E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.301600E-01
Normal-vs-NonDiabetic
6.238000E-01
Diabetic-vs-NonDiabetic
7.503200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.999760E-01
Normal-vs-NoPancreatitis
6.551400E-01
Pancreatitis-vs-NoPancreatitis
8.998400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.755800E-01
Normal-vs-N1
5.779800E-01
N0-vs-N1
4.252800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.110400E-01
Normal-vs-TP53-NonMutant
9.485200E-01
TP53-Mutant-vs-TP53-NonMutant
9.277900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
